These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20131873)

  • 1. Development of a point of care lateral flow device for measuring human plasma fibrinogen.
    Dudek MM; Lindahl TL; Killard AJ
    Anal Chem; 2010 Mar; 82(5):2029-35. PubMed ID: 20131873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibrinogen antigenic turbidimetric assay (FIATA): the X2x test--the corrected chi-square comparison against the control-mean.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):73-100. PubMed ID: 17164498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrinogen.
    Lowe GD; Rumley A; Mackie IJ
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):430-40. PubMed ID: 15588432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinogen functional turbidimetric assay.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):84-96. PubMed ID: 18160594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a fluorescent method for detecting the onset of coagulation in human plasma on microstructured lateral flow platforms.
    Dudek MM; Kent NJ; Gu P; Fan ZH; Killard AJ
    Analyst; 2011 May; 136(9):1816-25. PubMed ID: 21293802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A turbidimetric assay for quantitating functional fibrin(ogen) using polystyrene-divinylbenzene microparticles.
    Cook BC
    Anal Biochem; 1999 May; 270(1):83-7. PubMed ID: 10328768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
    Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
    Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic factors and coronary heart disease.
    Pilgeram LO
    Biomed Pharmacother; 1982; 36(4):187-9. PubMed ID: 7165789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative reagent-free detection of fibrinogen levels in human blood plasma using Raman spectroscopy.
    Poon KW; Lyng FM; Knief P; Howe O; Meade AD; Curtin JF; Byrne HJ; Vaughan J
    Analyst; 2012 Apr; 137(8):1807-14. PubMed ID: 22382127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen as a risk factor for coronary heart disease.
    Montalescot G; Collet JP; Choussat R; Thomas D
    Eur Heart J; 1998 Jul; 19 Suppl H():H11-7. PubMed ID: 9717059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
    Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
    Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
    Paton LN; Mocatta TJ; Richards AM; Winterbourn CC
    Free Radic Biol Med; 2010 Jan; 48(2):223-9. PubMed ID: 19857568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
    Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
    Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.